BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

28 أبريل 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

11 مارس 2025 07:30:01 بحسب Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

28 فبراير 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07 يناير 2025 08:00:01 بحسب Nasdaq GlobeNewswire

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

02 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results

05 نوفمبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

29 أكتوبر 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

01 أكتوبر 2024 09:00:01 بحسب Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

07 أغسطس 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Financial Results

06 أغسطس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

30 يوليو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus Reports First Quarter Financial Results

07 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

29 أبريل 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

12 مارس 2024 07:30:01 بحسب Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

04 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

18 يناير 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

12 يناير 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Bioventus Names Robert Claypoole as President and Chief Executive Officer

19 ديسمبر 2023 16:30:00 بحسب Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

06 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

07 نوفمبر 2023 07:00:01 بحسب Nasdaq GlobeNewswire